Abstract CT082: Impact of tumor mutation burden on the efficacy of first-line nivolumab in stage iv or recurrent non-small cell lung cancer: An exploratory analysis of CheckMate 026

2017 ◽  
Author(s):  
Solange Peters ◽  
Benjamin Creelan ◽  
Matthew D. Hellmann ◽  
Mark A. Socinski ◽  
Martin Reck ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Exploratory Analysis ◽  
Small Cell Lung ◽  
First Line ◽  
Tumor Mutation Burden ◽  
Mutation Burden

First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer

2005 ◽  
Author(s):  
Tobias Lange ◽  
Carsten Müller-Tidow ◽  
Hubert Serve ◽  
Petra Hoffknecht ◽  
Wolfgang Berdel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Systemic Treatment ◽  
Stage Iv ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line

Treatment intensity and duration in patients receiving first-line taxane chemotherapy for stage IV non-small cell lung cancer.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19011-e19011
Author(s):  
Jared Weiss ◽  
Rex W. Force ◽  
Brooke A. Pugmire ◽  
Teri Peterson ◽  
Claudio Faria ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Treatment Intensity ◽  
Small Cell Lung ◽  
First Line ◽  
Taxane Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document